Biosyntech (Biosyntech) COGS-to-Revenue : 1.00 (As of Dec. 2009)

View and export this data going back to 2000. Start your Free Trial

What is Biosyntech COGS-to-Revenue?

Biosyntech's Cost of Goods Sold for the three months ended in Dec. 2009 was $0.00 Mil. Its Revenue for the three months ended in Dec. 2009 was $0.00 Mil.

Biosyntech's COGS to Revenue for the three months ended in Dec. 2009 was 1.00.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Biosyntech's Gross Margin % for the three months ended in Dec. 2009 was 0.00%.

Biosyntech COGS-to-Revenue Historical Data

The historical data trend for Biosyntech's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biosyntech COGS-to-Revenue Chart

Biosyntech Annual Data

Trend

Mar00

Mar01

Mar02

Mar03

Mar04

Mar05

Mar06

Mar07

Mar08

Mar09

COGS-to-Revenue

Get a 7-Day Free Trial

0.45

0.35

0.37

0.38

Biosyntech Quarterly Data
	Mar05	Jun05	Sep05	Dec05	Mar06	Jun06	Sep06	Dec06	Mar07	Jun07	Sep07	Dec07	Mar08	Jun08	Sep08	Dec08	Mar09	Jun09	Sep09	Dec09
COGS-to-Revenue	Get a 7-Day Free Trial															0.50	0.32	0.41	0.32	1.00

Biosyntech COGS-to-Revenue Calculation

Biosyntech's COGS to Revenue for the fiscal year that ended in Mar. 2009 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0.012	/	0.032
	=	0.38

Biosyntech's COGS to Revenue for the quarter that ended in Dec. 2009 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0.001	/	0.001
	=	1.00

Biosyntech (OTCPK:BSYI) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Biosyntech's Gross Margin % for the three months ended in Dec. 2009 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	0.001 / 0.001
	=	0.00 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Biosyntech COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Biosyntech's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Biosyntech (Biosyntech) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biosyntech Inc (OTCPK:BSYI) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

475 Boulevard Armand-Frappier, Laval, QC, CAN, H7V 4B3

Website

http://www.biosyntech.com

Biosyntech Inc is engaged in developing advanced biotherapeutics thermogels specifically designed for tissue repair and delivery of therapeutic agents. The company's products include BST-CarGel, BST-InPod, BST-DermOn, BST-Ossifil and BST-Ossifix and BST-Disc for intervertebral disc restoration.

Biosyntech (Biosyntech) Headlines

No Headlines